Specific ¹²⁵I Neuropeptide Y Binding to Intact Cultured Bovine Adrenal Medulla Capillary Endothelial Cells

References

• Allen JM, Adrian TE, Polak JM, Bloom SR. Neuropeptide Y in the adrenal gland. J Auton Nerv Syst 1983; 9: 559–563
   PubMedGoogle Scholar
• Andriantsitohaina R, Stoclet JC. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries. Br J Pharmacol 1988; 95: 419–428
   Google Scholar
• Bastiaensen E, De Block J, De Potter WP. Neuropeptide Y is localized together with enkephalins in adrenergic granules of bovine adrenal medulla. J Neurosci 1988; 25: 679–686
   Google Scholar
• Chang R SL, Lotti VJ, Chen TB, Cerino DJ, Kling PJ. Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: Comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens. Life Sci 1985; 37: 2111–2122
   Google Scholar
• Cherdchu C, Deupree JD, Hexum TD. Binding sites for neuropeptide Y (NPY) on membranes from bovine adrenal medulla. Eur J Pharmacol 1989; 173: 115–119
   Google Scholar
• Dahlöf C, Dahlöf P, Lundberg JM. Neuropeptide Y (NPY): enhancement of blood pressure increase upon α-adrenoceptor activation and direct pressor effects in pithed rats. Eur J Pharmacol 1985; 109: 289–292
   PubMed Web of Science ®Google Scholar
• Dahlöf P, Persson K, Lundberg JM, Dahlöf C. Neuropeptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenalin and noradrenaline in the pithed rat. Acta Physiol Scand 1988; 132: 51–57
   PubMedGoogle Scholar
• DeQuidt ME, Emson PC. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 1986; 18: 545–618
   Google Scholar
• Dumont Y, Martel J-C, Fournier A, St-Pierre S, Quiron R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 1992; 38: 125–167
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R. Neuropeptide Y: cerebrovascular innervation and vasomotor effect in the cat. Neurosci Lett 1983; 43: 79–84
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Ekblad E, Hakånson R, Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984; 83: 519–525
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Håkanson R, Wahlestedt C, Uddman R. Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 1987; 8: 231–235
   Web of Science ®Google Scholar
• Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Håkanson R, Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 1984; 8: 225–235
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of smooth muscle by acetylcholine. Nature 1980; 288: 373–376
   PubMed Web of Science ®Google Scholar
• Gray TS, Morley JE. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci 1986; 38: 389–401
   PubMed Web of Science ®Google Scholar
• Hexum TD, Russet LR. Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y. Neuropeptides 1989; 13: 35–41
   Google Scholar
• Higuchi H, Costa E, Yang H-YT. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells. J Pharmacol Exp Ther 1988; 244: 468–474
   PubMed Web of Science ®Google Scholar
• Kassis S, Olasmaa M, Terenius L, Fishman PH. Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J Biol Chem 1987; 262: 3429–3431
   PubMed Web of Science ®Google Scholar
• Kawamura K, Smith TL, Zhou Q, Kummerow FA. Neuropeptide Y stimulates prostacyclin production in porcine vascular endothelial cells. Biochem Biophy Res Commun 1991; 179: 309–313
   Google Scholar
• Lundberg JM, Stjärne L. Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand 1984; 120: 477–479
   PubMedGoogle Scholar
• Lundberg JM, Änggård A, Theodorsson-Norheim E, Pernow J. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci Lett 1984; 52: 175–180
   PubMed Web of Science ®Google Scholar
• Lundberg JM, Hökfelt T, Hemsen A, Theodorsson-Norheim E, Pernow J, Hamberger B, Goldstein M. Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumor and plasma of phaeochromocytoma tumor patients. Regul Pept 1986; 13: 169–180
   PubMedGoogle Scholar
• Majane EA, Alho H, Kataoka Y, Lee CH, Yang H-YT. Neuropeptide Y in bovine adrenal glands: distribution and characterization. Endocrinology 1985; 117: 1162–1168
   PubMed Web of Science ®Google Scholar
• Olasmaa M, Påhlman S, Terenius L. b˜-Adrenoceptor, vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) receptors functionally coupled to adenylate cyclase in the human neuroblastoma SK-N-MC cell line. Neurosci Lett 1987; 83: 161–166
   PubMed Web of Science ®Google Scholar
• Pernow J, Saria A, Lundberg JM. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol Scand 1986; 126: 239–249
   PubMedGoogle Scholar
• Petrenko S, Olianas MC, Onali P, Gessa GL. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus. Eur J Pharmacol 1987; 136: 425–428
   PubMedGoogle Scholar
• Quirion R, Martel JC, Dumont Y, Cadieux A, Jolicoeur F, St-Pierre S, Fournier A. Neuropeptide Y receptors: autoradiographic distribution in brain and structure-activity relationships. Ann NY Acad Sci 1990; 611: 58–72
   Google Scholar
• Saria A, Theodorsson-Norheim E, Lundberg JM. Evidence for specific Neuropeptide Y binding sites in rat brain synaptosomes. Eur J Pharmacol 1985; 107: 105–107
   Google Scholar
• Schwartz TW, Sheikh SP, O'Hare M MT. Receptors on phaeochromocytoma cells for two members of the PP-fold family-NPY and PP. FEBS Lett 1987; 225: 209–214
   Google Scholar
• Sheikh SP, O'Hare M MT, Tortora O, Schwartz TW. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines. J Biol Chem 1989; 264: 6648–6654
   PubMed Web of Science ®Google Scholar
• Sheikh SP, Roach E, Fuhlendorff J, Williams JA. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Am J Physiol 1991; 260: G250–G257
   PubMed Web of Science ®Google Scholar
• Silva WI, Santiago N, García-Arrarás JE, Carrasquillo B. Electroimmunoblotting of neuropeptide Y: application to the rat vas deferens. Neurosci Lett 1990; 109: 191–195
   Google Scholar
• Sung C-P, Arleth AJ, Feuerstein GZ. NPY upregulates the adhesiveness of human endothelial cells for leukocytes. Circ Res 1991; 68: 314–318
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM. Endothelium and the control of vascular tissue. News Physiol Sci 1987; 2: 18–22
   Google Scholar
• Varndell IM, Polak JM, Allen JM, Terenghi G, Bloom SR. Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. Endocrinology 1984; 114: 1460–1462
   PubMed Web of Science ®Google Scholar
• Wahlestedt C, Regunathan S, Reis DJ. Identification of cultured cells selectively expressing Y1, Y2 or Y3-type receptors for neuropeptide Y/Peptide YY. Life Sci 1992; 50, PL7–PL12.
   Google Scholar
• Westlind-Danielsson A, Andell J, Abens J, Bartfai T. Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum. Acta Physiol Scand 1988; 132: 425–430
   Google Scholar